Fosravuconazole Uses, Dosage, Side Effects and more
Fosravuconazole is under investigation in clinical trial NCT03378661 (BENDITA BEnznidazole New Doses Improved Treatment and Associations).
| Trade Name | Fosravuconazole |
| Generic | Fosravuconazole |
| Fosravuconazole Other Names | Fosravuconazole |
| Type | |
| Formula | C23H20F2N5O5PS |
| Weight | Average: 547.47 Monoisotopic: 547.089083262 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
